Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:33 PM
Ignite Modification Date:
2025-12-24 @ 3:33 PM
NCT ID:
NCT00383292
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of malignant melanoma that is unresectable or metastatic (Stage III or IV)
* Have received 1 previous systemic treatment regimen for unresectable or metastatic melanoma. An immunotherapy or antibody-based regimen (including vaccination-based treatments) is not counted as a prior treatment regimen for determining study eligibility, unless it was combined with a chemotherapeutic or targeted anti-cancer drug.
* Have discontinued all previous therapies for cancer, including chemotherapy, radiotherapy, immunotherapy, or other investigational therapy for at least 30 days
Exclusion Criteria:
* Serious pre-existing medical conditions
* Have received two or more previous treatment regimens for unresectable or metastatic melanoma
* Have a second primary cancer (unless disease-free to more than 2 years)
* Active treatment with Warfarin (Coumadin)
* Primary ocular or mucosal melanoma
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00383292
Study Brief:
Protocol Section:
NCT00383292